Pharmaceutical

US DoD enlists VitriVax to develop one-shot vaccine for melioidosis

B. pseudomallei is resistant to many antibiotics and, without treatment, can be lethal to those infected.

Jul 19, 2023 - 20:00
US DoD enlists VitriVax to develop one-shot vaccine for melioidosis
B. pseudomallei is resistant to many antibiotics and, without treatment, can be lethal to those infected.
Read the original article

Tags:

Previous Article

Amarin restructures to counter downturn following Vascepa generics

Next Article

Santhera and Catalyst to market DMD drug vamorolone in North America

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Lead aprons not necessary for patients during X-rays, says largest U.S. dental group

Lead aprons not necessary for patients during X-rays, s...

Feb 3, 2024

When did Wall Street sour on Lilly’s Alzheimer’s drug?

When did Wall Street sour on Lilly’s Alzheimer’s drug?

Mar 13, 2024

STAT+: With an old approach but new energy, ADCs take center stage as promising cancer treatments

STAT+: With an old approach but new energy, ADCs take c...

Oct 24, 2023